Junshi Biosciences and Coherus Announce Toripalimab First-Line Nasopharyngeal Carcinoma Clinical Data to be Showcased in Plenary Session at 2021 ASCO Annual Meeting

NEXT STORY
Global clinical trials market was valued at USD51.25 billion in 2020 and is anticipated to reach USD77.20 billion by 2026
PREV STORY
HOOKIPA Pharma to Participate in Upcoming Investor Conferences in May
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

FIT Biotech Oy: FIT Biotech webcasts the company half-year financial report on September 6th 2018, at 10.00 AM.

FIT Biotech Oy                                                                                               Press Release July 3rd 2018, 08.30 EET FIT Biotech webcasts the ...

author_avatar
NASDAQ Market News

Medivir proceeds with a separation of the company’s operations

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the Board of ...

author_avatar
NASDAQ Market News

Helomics® Corporation and Ariel Precision Medicine, Inc. sign a services agreement to Advance Clinical Genomics in Precision Medicine Applications

PITTSBURGH, Dec. 20, 2017 (GLOBE NEWSWIRE) -- Helomics® Corporation (Helomics), a privately-held, healthcare company providing personalized medicine ...

author_avatar
NASDAQ Market News